By Christy Santhosh (Reuters) -AbbVie said on Monday it would acquire privately held cell therapy developer Capstan ...

AbbVie ABBV-2.40%decrease; red down pointing triangle agreed to acquire Capstan Therapeutics, including its lead asset, for $2.1 billion in cash. The North Chicago, Ill., drugmaker’s planned ...

June 30 (Reuters) - U.S. drugmaker AbbVie (ABBV.N), opens new tab said on Monday it will acquire cell therapy developer Capstan Therapeutics in a cash deal worth up to $2.1 billion. Capstan develops ...